Showing results (61-70 of 842) with videos related to

Sort By:
Pageof 85
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysisJ T Hartmann, L Einhorn, C R Nichols, et al.
International Journal of Cancer|December 22, 1999
Platinum organ toxicity and possible prevention in patients with testicular cancerJ T Hartmann, C Kollmannsberger, L Kanz, et al.
Onkologie|September 28, 2001
[Treatment of multiple myeloma in elderly patients: consensus of the Geriatric Oncology Working Group of the German Society of Hematologic Oncology and the German Society of Geriatrics]I Genvresse, U Wedding, C Bokemeyer, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1988
Growth requirements, growth factor responsiveness, and growth factor secretion of three human embryonal carcinoma cell linesW Verbeek, C Bokemeyer, H Falk, et al.
Investigational New Drugs|January 1, 1997
Pre-clinical activity of taxol in non-seminomatous germ cell tumor cell lines and nude mouse xenograftsT A Dunn, V Grünwald, C Bokemeyer, et al.
Deutsche Medizinische Wochenschrift (1946)|October 1, 2014
[Current treatment concepts for castration resistant prostate cancer]G von Amsberg, P Stroelin, C Bokemeyer, et al.
Andrology|March 30, 2019
Epigenetic treatment combinations to effectively target cisplatin-resistant germ cell tumors: past, present, and future considerationsC Oing, M A Skowron, C Bokemeyer, et al.
The Journal of Urology|November 1, 1993
Familial occurrence of Leydig cell tumors: a report of a case in a father and his adult sonC Bokemeyer, M Kuczyk, P Schöffski, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 25, 2015
The impact of social factors on outcomes in patients with bleeding disordersK Holstein, S von Mackensen, C Bokemeyer, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2003
Analysis of salvage treatments for germ cell cancer patients who have relapsed after primary high-dose chemotherapy plus autologous stem cell supportC Kollmannsberger, N Schleucher, O Rick, et al.
Pageof 85